EntryPoint Capital’s Structure Therapeutics GPCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,260
Closed -$360K 775
2024
Q4
$360K Buy
13,260
+8,095
+157% +$220K 0.15% 258
2024
Q3
$227K Buy
5,165
+1,480
+40% +$65K 0.13% 386
2024
Q2
$145K Buy
3,685
+3,467
+1,590% +$136K 0.21% 136
2024
Q1
$9.34K Sell
218
-7,617
-97% -$326K 0.01% 1245
2023
Q4
$319K Buy
+7,835
New +$319K 0.31% 18